ArticleSurgical case reports2026
Sequential Flow-Based Assessment of a Suspected Inferior Pancreaticoduodenal Artery-Derived Pathway Entering the Right Hepatic Artery during Pancreaticoduodenectomy: A Case Report.
Article in Surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDuring pancreaticoduodenectomy (PD), hepatic arterial ischemia is usually considered in patients with celiac artery stenosis or occlusion, in whom the gastroduodenal artery (GDA)-based pancreaticoduodenal arcade may serve as a critical collateral pathway. However, a similar but atypical pitfall may exist when the GDA and anterior superior pancreaticoduodenal artery (ASPDA) are absent: a prominent inferior pancreaticoduodenal artery (IPDA)-derived pathway may raise concern regarding hepatic inflow despite the anatomical presence of the common hepatic artery (CHA). CASE PRESENTATION: A 75-year-old man with distal bile duct cancer underwent preoperative evaluation for PD. Contrast-enhanced CT showed an anatomically identifiable CHA measuring 3.4 mm, whereas the GDA and ASPDA were absent. A markedly developed IPDA-derived arterial pathway coursed cranially from the superior mesenteric artery and appeared to enter the main trunk of the right hepatic artery (RHA) within the hepatoduodenal ligament, raising concern that its division might affect hepatic arterial inflow. Balloon occlusion was performed immediately proximal to the point where the pathway appeared to enter the RHA. During occlusion, aortography showed opacification of the CHA and RHA through the CHA without visually apparent delay. Intraoperatively, temporary clamping with indocyanine green fluorescence imaging showed visually uniform liver surface fluorescence without a subjective right-left difference in fluorescence onset. The pathway was divided, and PD was completed without median arcuate ligament release or arterial reconstruction. Postoperative contrast-enhanced CT on POD 6 confirmed preserved hepatic arterial opacification without ischemic changes.
conclusionsAn anatomically identifiable CHA does not necessarily guarantee secure hepatic arterial inflow during PD. When the GDA and ASPDA are absent and an IPDA-derived pathway is markedly developed, functional assessment should be considered before irreversible arterial division.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.